Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statins in Septic Shock
NCT02681653Completed
- Sponsor
- Sanjay Gandhi Postgraduate Institute of Medical Sciences
- Start
- Jan 2012
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of atorvastatin in septic shock (2 arms), sponsored by Sanjay Gandhi Postgraduate Institute of Medical Sciences. Primary endpoint: Mortality at 28 days. Started Jan 2012; status: completed.
02
Drugs
atorvastatin
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT02681653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02681653.